These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 21398061

  • 41. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
    Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O.
    Technol Cancer Res Treat; 2006 Aug; 5(4):401-10. PubMed ID: 16866570
    [Abstract] [Full Text] [Related]

  • 42. Men with breast cancer have same disease-specific and event-free survival as women.
    Marchal F, Salou M, Marchal C, Lesur A, Desandes E.
    Ann Surg Oncol; 2009 Apr; 16(4):972-8. PubMed ID: 19184227
    [Abstract] [Full Text] [Related]

  • 43. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.
    Truong PT, Lesperance M, Li KH, MacFarlane R, Speers CH, Chia S.
    Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215
    [Abstract] [Full Text] [Related]

  • 44. Perfusion Parameters on Breast Dynamic Contrast-Enhanced MRI Are Associated With Disease-Specific Survival in Patients With Triple-Negative Breast Cancer.
    Park VY, Kim EK, Kim MJ, Yoon JH, Moon HJ.
    AJR Am J Roentgenol; 2017 Mar; 208(3):687-694. PubMed ID: 28004976
    [Abstract] [Full Text] [Related]

  • 45. Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
    Wang C, Wei W, Santiago L, Whitman G, Dogan B.
    Acta Radiol; 2018 Jul; 59(7):813-821. PubMed ID: 29105486
    [Abstract] [Full Text] [Related]

  • 46. Quantitative discrimination between invasive ductal carcinomas and benign lesions based on semi-automatic analysis of time intensity curves from breast dynamic contrast enhanced MRI.
    Yin J, Yang J, Han L, Guo Q, Zhang W.
    J Exp Clin Cancer Res; 2015 Mar 04; 34(1):24. PubMed ID: 25887917
    [Abstract] [Full Text] [Related]

  • 47. Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors.
    Tuncbilek N, Karakas HM, Okten OO.
    Eur J Radiol; 2005 Mar 04; 53(3):500-5. PubMed ID: 15741025
    [Abstract] [Full Text] [Related]

  • 48. Long-term Survival Outcomes of Primary Breast Cancer in Women With or Without Preoperative Magnetic Resonance Imaging: A Matched Cohort Study.
    Choi WJ, Cha JH, Kim HH, Shin HJ, Chae EY, Jung KH, Ahn JH, Kim SB, Son BH, Ahn SH.
    Clin Oncol (R Coll Radiol); 2017 Oct 04; 29(10):653-661. PubMed ID: 28728883
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Computer assisted analysis of MR-mammography reveals association between contrast enhancement and occurrence of distant metastasis.
    Baltzer PA, Zoubi R, Burmeister HP, Gajda M, Camara O, Kaiser WA, Dietzel M.
    Technol Cancer Res Treat; 2012 Dec 04; 11(6):553-60. PubMed ID: 22568630
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor Model.
    Wu M, Lu L, Zhang Q, Guo Q, Zhao F, Li T, Zhang X.
    PLoS One; 2016 Dec 04; 11(2):e0149279. PubMed ID: 26901876
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer data.
    Asano J, Hirakawa A, Hamada C.
    Pharm Stat; 2014 Dec 04; 13(6):357-63. PubMed ID: 25044997
    [Abstract] [Full Text] [Related]

  • 57. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer.
    Yuh WT, Mayr NA, Jarjoura D, Wu D, Grecula JC, Lo SS, Edwards SM, Magnotta VA, Sammet S, Zhang H, Montebello JF, Fowler J, Knopp MV, Wang JZ.
    Invest Radiol; 2009 Jun 04; 44(6):343-50. PubMed ID: 19661844
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Estimation and prediction in a multi-state model for breast cancer.
    Putter H, van der Hage J, de Bock GH, Elgalta R, van de Velde CJ.
    Biom J; 2006 Jun 04; 48(3):366-80. PubMed ID: 16845902
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.